Activity

  • Jenny Rose Hernando posted an update in the group Group logo of MT 30 - GH (Lec)MT 30 – GH (Lec) 4 years, 4 months ago

    NAFLD stands for non-alcoholic fatty liver disease, which refers to a group of disorders caused by a build-up of fat in the liver. For more details, see the link I provided, which leads to an article regarding NAFDL. Also, be guided by the fact that I have provided my own analysis on this matter in the comment section. Thank you so much, and have a wonderful day!

    • Nonalcoholic fatty liver disease (NAFLD) refers to a group of liver diseases that affect persons who use little or no alcohol. NAFLD is characterized by excessive fat storage in liver cells, as the term implies. It is most common in overweight or obese people. High levels of fat in the liver are linked to an increased risk of significant health issues like diabetes, high blood pressure, and renal disease. NAFLD raises your chances of getting cardiac problems if you already have diabetes. It is possible to prevent NAFLD from worsening and lower the amount of fat in your liver if it is discovered and treated early.

      Nonalcoholic fatty liver disease (NAFLD) is becoming more common over the world at the same time as diabetes and obesity are becoming more common. Nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH) are two types of NAFLD based on liver pathology (NASH). NASH is a clinically advanced type of NAFL that can proceed to cirrhosis and eventually hepatocellular cancer in rare circumstances. In addition to lobular inflammation, it is characterized by fibrosis, hepatocytes with macrovesicular steatosis, and ballooning. Hepatocytes with macrovesicular steatosis but no inflated hepatocytes are classified as NAFL.

      To enhance the histological and biochemical characteristics of NAFLD, we examine the role of antioxidants, cytokines, nuclear transcription factor modulation, insulin-sensitizing drugs, lipid modifying agents, gastrointestinal hormones, and antifibrotic therapy. The US Food and Drug Administration (FDA) has not yet approved any medicines or other treatments to prevent or cure NAFLD. Vitamin E (an antioxidant) and pioglitazone are the two best medication alternatives for biopsy-proven NASH, according to the American Association for the Study of Liver Diseases (used to treat diabetes).

    you're currently offline

    0

    New Report

    Close